Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
EDEN PRAIRIE, Minn., May 01, 2018 -- CHF Solutions, Inc. (Nasdaq:CHFS) announces today that its first quarter financial results will be released on Tuesday, May 8, 2018. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at https://edge.media-server.com/m6/p/dxgvnn8x. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID 8694787. An audio archive of the webcast and the call script will be available following the call on the Investor page at www.chf-solutions.com.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
CONTACTS:
INVESTORS:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205
[email protected]
-or-
Bret Shapiro
Managing Partner
CORE IR
516-222-2560
[email protected]
www.coreir.com
MEDIA
Jules Abraham
JQA Partners, Inc.
917-885-7378
[email protected]
